PT - JOURNAL ARTICLE AU - Rajiv Bhatia TI - Quantitative Estimation of Covid-19 Related Unemployment On Suicide and Excess Mortality in the United States AID - 10.1101/2020.05.02.20089086 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.02.20089086 4099 - http://medrxiv.org/content/early/2020/05/08/2020.05.02.20089086.short 4100 - http://medrxiv.org/content/early/2020/05/08/2020.05.02.20089086.full AB - Introduction To date, reducing virus transmission to mitigate demand on health care systems has been a singular objective of Covid-19 policy action. This aim has driven widespread and rapid application of untested policies to control contagion, including the deployment of non-pharmaceutical interventions (NPIs), including travel restrictions, bans on gathering, and community-wide lockdowns. Risk models, public health experts and political leadership alike have given almost no attention to related, anticipated, and predictable societal and health impacts likely to result from behavioral responses to Covid-19 combined with the application of NPIs.Methods This analysis demonstrates a standard risk assessment approach to quantify the impacts of Covid-19 unemployment in the United States on suicide and all cause mortality.Results Applying observational epidemiological data to the population recently unemployed predicts 7444 deaths from suicide in the coming year and 556,000 avoidable deaths from all causes over the next ten years.Discussion Indirect health impacts of societal responses to Covid-19 are likely and quantifiable. Decision-makers can now include indirect health impacts into their policy making calculus for Covid-19 to strike a balance between the benefits and costs of mitigation. A full trade-offs analysis of alternative planning scenarios will likely reveal multiple unconsidered ethical challenges that need transparent public discussion and solution.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThe author received no funding or compensation for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this analysis is publicly available without a fee. https://www.bls.gov/cps/cpsaat03.htm https://www.cdc.gov/nchs/products/databriefs/db355.htm